Top Markets
Coin of the day
Actavia Life Sciences, Inc. Actavia Life Sciences, Inc.

Actavia Life Sciences, Inc.

RASP
Rank in Stocks #39683
Actavia Life Sciences, Inc. operates as a biotechnology enterprise specializing... Actavia Life Sciences, Inc. operates as a biotechnology enterprise specializing in the development of therapeutic solutions aimed at treating various forms of leukemia and lymphoma. Additionally, the company is engaged in formulating small molecule drug candidates, with a particular emphasis on addressing acute myeloid leukemia. Established in 2013, its corporate headquarters are situated in New York, NY.
Share Price
$0.0005
Last synced: 2026-08-12
Market Cap
$385.91K
Change (1 day)
0.00%
Change (1 year)
-87.50%
Country
US
Trade Actavia Life Sciences, Inc. (RASP)

Category

P/B ratio for Actavia Life Sciences, Inc. (RASP)
P/B ratio as of 2026 TTM: 0
According to Actavia Life Sciences, Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Actavia Life Sciences, Inc. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.2613 -
US
6.3483 -
NL
- -
CH
- -
KR
3.634 -
BE